Trials / Completed
CompletedNCT04684771
Tolerance, Efficacy, revAlidation, Myostim
Evaluation of Efficacy and Tolerance of a Food Supplement (MYOSTIM®) in Postoperative Revalidation of Patients After Reconstructive Surgery of Anterior Cruciate Ligament
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Alternativa International S.A · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of efficacy and tolerance of a food supplement (MYOSTIM®) versus a placebo in postoperative revalidation of patients after reconstructive surgery of anterior cruciate ligament. The food supplement (MYOSTIM®) has been developped and is supplied as food bars and composed of pomegranate, leucine, creatine, proteins and D vitamin. The aim of this exploratory study is to assess the efficacy and tolerance of MYOSTIM® on muscle performance after ACL reconstructive surgery and in postoperative revalidation phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | MYOSTIM® | Food supplement n° NCT 2485/8 (Red fruits flavor bar) and NCT 2485/7 (Black chocolate flavor bar) delivered by the Federal Public Service, Health, Food chain safety and environment. |
| DIETARY_SUPPLEMENT | PLACEBO | Bars with no active ingredient and the same flavor (chocolate and red fruits). |
Timeline
- Start date
- 2015-03-23
- Primary completion
- 2017-07-27
- Completion
- 2017-12-31
- First posted
- 2020-12-28
- Last updated
- 2020-12-28
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04684771. Inclusion in this directory is not an endorsement.